Bayh-Dole Act is a United States federal law enacted in 1980 that allows universities, nonprofit research institutions, and small businesses to retain ownership of inventions developed with federal funding and to license those inventions exclusively to commercial partners. Formally titled the Patent and Trademark Law Amendments Act, the legislation fundamentally reshaped the relationship between academic research and commercial innovation by transferring patent rights from the federal government to the research performers who made the inventions. The law is widely credited with catalyzing the modern technology transfer ecosystem, enabling thousands of university spin-off companies and generating billions in economic activity from federally funded research discoveries.
Bayh-Dole Act
| |
|---|---|
| Category | IP Strategy, Regulation |
| Subfield | Technology Transfer, Patent Law, Innovation Policy |
| Year Enacted | 1980 |
| Key Provision | University Ownership of Federally Funded Inventions |
| Primary Impact | University Licensing, Startup Formation, Industry-Research Collaboration |
| Sources: Congress.gov Bayh-Dole Act, AUTM Technology Transfer Survey, Nature Biotechnology Bayh-Dole Review | |
Other Names
Patent and Trademark Law Amendments Act, university patent act, Bayh-Dole legislation
History
Before the Bayh-Dole Act, inventions developed with federal funding belonged to the government, which held over 28,000 patents by 1980 but licensed fewer than 5 percent for commercial development. Without exclusive patent rights, companies would not invest in developing raw research discoveries into commercial products.
Introduced by Senators Birch Bayh and Bob Dole, the act passed with broad bipartisan support and was signed by President Jimmy Carter in December 1980. Before 1980, fewer than 25 universities had technology transfer offices; by 2025, over 400 managed over 100,000 active licenses. Landmark inventions commercialized under Bayh-Dole include Google’s search algorithm (Stanford), Gatorade (University of Florida), and CRISPR gene-editing patents (University of California and the Broad Institute).
How the Bayh-Dole Act Works
Universities receiving federal funding must disclose inventions to the funding agency within two months, elect to retain title within two years, and file patent applications within one year of electing title. In exchange, universities must give preference to small businesses for exclusive licenses and share licensing revenue with inventors.
Key Provisions
The core mechanism grants universities the right to retain ownership of federally funded inventions, to license exclusively or non-exclusively, and to retain revenue. The government retains a nonexclusive license for government purposes and reserves march-in rights to compel licensing if the invention is not commercialized for public health or safety needs.
Real-World Applications and Impact
Stanford’s licensing of the Google search algorithm for 1.8 million shares, later sold for over $300 million, exemplifies Bayh-Dole’s economic potential. The Association of University Technology Managers reports that university licensing has supported over 15,000 startups and contributed over $1 trillion to U.S. economic output since 1996.
Benefits of Bayh-Dole
The primary benefit is commercialization of federally funded research that previously remained undeveloped. Exclusive licenses provide the certainty companies need to invest the substantial resources required to transform raw discoveries into products, a process typically requiring 5-15 years and tens of millions of dollars per product.
Limitations and Challenges
Critics argue Bayh-Dole has shifted universities from their public mission toward commercial priorities. The march-in rights provision has never been successfully used, raising questions about whether the public receives fair value for its $70 billion annual basic research investment, particularly when exclusively licensed drugs result in high prices.
Current Debates
The central debate concerns whether march-in rights should be used to control drug prices. Advocacy groups have petitioned the NIH to exercise march-in rights for expensive drugs developed with federally funded research including Xtandi and remdesivir, but no administration has ever granted such a petition.
Media Depictions
- The Social Network (2010): The tension between Harvard’s technology transfer office and Mark Zuckerberg illustrates how university IP policies shape commercialization of student inventions.
- The Patent Wars (2018) by Fredrik Jorgensen: Examines how Bayh-Dole transformed university-industry relationships and debates over access to publicly funded inventions.
- AUTM Database: The Association of University Technology Managers maintains the comprehensive database of U.S. university licensing activity used to evaluate Bayh-Dole’s impact.
Research Landscape
Current research examines Bayh-Dole’s impact on drug prices, technology transfer effectiveness across university types, international adoption of similar legislation in Japan, Germany, and the UK, and proposals to reform march-in rights.
Frequently Asked Questions
What exactly is the Bayh-Dole Act?
A 1980 U.S. law allowing universities to own and license inventions made with federal research funding, enabling their commercial development.
Why was Bayh-Dole necessary?
Before Bayh-Dole, fewer than 5 percent of federally funded inventions were commercialized because companies would not invest without exclusive patent rights.
Does Bayh-Dole apply to all research?
It applies to universities, nonprofits, and small businesses; large corporations must negotiate separate rights with funding agencies.
